Logo

diabetes

Research Triangle Institute Partners With GeneDx, Illumina for Expanded Newborn Screening Study

The study will offer whole-genome sequencing and genetic risk scores for type 1 diabetes for newborns born in North Carolina.

Blood Lipidome Profiles Linked to Aging, Health Measures in Quantitative Study

A longitudinal study linked the composition and levels of blood lipids to health, aging, viral infections, and metabolic conditions such as insulin resistance.

Large-Scale Proteomic Studies Identify Proteins Linked to Diabetes, Metabolic Syndrome

The two studies, published separately in Cell Reports Medicine, used affinity-based and mass spec platforms to analyze thousands of blood samples.

Chinese Population Biobank Highlights Genetic Diversity, Disease Associations

Researchers looked for genetic contributors to more than 200 conditions in individuals from 10 populations, leading to new and known risk variants.

Type 2 Diabetes, Osteoarthritis Comorbidity Traced to Obesity-Related Processes

Researchers turned to genotyping, multiomics, and functional studies to untangle the processes contributing to type 2 diabetes and hip/knee osteoarthritis.

Jul 7, 2023

Epigenetic Study Finds Novel Associations Between DNA Methylation, Common Diseases

Jun 30, 2023

Autoimmunity, Type 1 Diabetes Predicted by Plasma Protein Biomarkers

May 25, 2023

Hong Kong Researchers Mine Epigenetic Data to Predict Diabetic Kidney Disease, Failure
Premium

May 4, 2023

MultiOmic Health Raises £5M in Seed Funding Extension Round

Mar 13, 2023

DnaNudge, Mylab Discovery Solutions Forge Dx Partnership for Diabetic Foot Infections

Jan 23, 2023

Type 2 Diabetes Mechanisms, Risk Genes Identified in GWAS Meta-Analysis

Nov 16, 2022

Exome Sequencing Study Identifies Potential Treatment Target for Diabetes

Oct 25, 2022

Diabetes Polygenic Risk Score Performance Improved by Addition of Rare Variants

Oct 10, 2022

Genomics PLC to Provide Polygenic Risk Scores for UK's Our Future Health Research Program

Jul 13, 2022

Family History Improves Polygenic Risk Scores for Complex Disease in Non-Europeans

May 13, 2022

Type 2 Diabetes Multi-Ancestry GWAS Enables Risk Prediction Across Populations

Apr 28, 2022

Million Veteran Program Study Links Genetic Variants Related to Severe COVID-19 to Other Conditions

Apr 18, 2022

Clinical Polygenic Risk Assay, Reporting Pipeline Shows Promise for Multiple Conditions
Premium

Apr 13, 2022

Common Disease Polygenic Risk Scores Show Poor Cross-Ancestry Performance

Apr 7, 2022

Post-Transplant Diabetes Risk Informed by Polygenic Risk Profiles in Donors, Recipients

Mar 24, 2022

New TWAS Method Helps Analyze Data From Multiple Genetic Ancestries

Feb 17, 2022

UK Biobank Exome Study Uncovers Rare Variants Contributing to Cardiometabolic Disease, Traits

Feb 14, 2022

Cardiometabolic Disease Shows Ties to Depressive Mood, Irrespective of Genetic Risk

Nov 5, 2021

Diabetes Subtypes Stem From Distinct Genetic Contributors, Study Suggests

Sep 15, 2021

Broad Institute, Novo Nordisk Foundation Launch Center to Study Genomic Mechanisms of Disease

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.